MESA LABORATORIES INC /CO/ 10-Q

Item 1A. Risk factors   During the nine months ended December 31, 2022, there were no material changes from the risk factors described in Item 1A.  Risk Factors of our Annual Report on Form 10-K for the year ended March 31, 2022.    I tem 2. Unregistered Sales of Equity Securities and Use of Proceeds   Issuer Purchases of Equity Securities   The following table provides information about the Company's purchases of equity securities for the periods indicated:       Total Number of Shares Purchased(1)     Average Price Paid Per Share     Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs(2)     Maximum Number of Shares That May Yet be Purchased Under the Plans or Programs   October 2022     -       -       -       162,486   November 2022     (1,757 )     188.96       -       162,486   December 2022     -       -       -       162,486   Total     (1,757 )     188.84       -       162,486       (1) Shares purchased during the period were transferred to the Company from employees in satisfaction of minimum tax withholding obligations associated with the vesting of restricted stock awards during the period.   (2) On November 7, 2005, our Board of Directors adopted a share repurchase plan which allows for the repurchase of up to 300,000 of our common shares; however, no shares have been purchased under the plan in the last three fiscal years. This plan will continue until the maximum is reached or the plan is terminated by further action of the Board of Directors.     Page 23 Table of Contents   Item 6. Exhibits   Exhibit No. Description of Exhibit 3.1 Articles of Incorporation and Amendments to Articles of Incorporation (incorporated by reference from exhibit 3.1 to Mesa Laboratories, Inc. ’ s report on Form 10-Q filed on July 31, 2018 (Commission File Number: 000-11740)). 3.2 Amended and Restated Bylaws of Mesa Laboratories, Inc. (incorporated by reference from exhibit 3.1 to the Current Report on Form 8-K filed on May 10, 2019 (Commission File Number: 000-11740)). 10.1+ Amendment No. 1 to Credit Agreement dated as of December 22, 2022 among the Company, the lenders party thereto, and JPMorgan Chase Bank, NA., as administrative agent. 31.1+ Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 31.2+ Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 32.1* Certification of Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 32.2* Certification of Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 101.INS+ XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. 101.SCH+ Inline XBRL Taxonomy Extension Schema Document. 101.CAL+ Inline XBRL Taxonomy Extension Calculation Linkbase Document 101.DEF+ Inline XBRL Taxonomy Extension Definitions Linkbase Document 101.LAB+ Inline XBRL Taxonomy Extension Label Linkbase Document 101.PRE+ Inline XBRL Taxonomy Extension Presentation Linkbase Document 104+ Cover Page Interactive Data File (formatted as Inline XBRL with applicable taxonomy extension information contained in Exhibits 101.*).   + Filed herewith * Furnished herewith   Page 24 Table of Contents   Signatures   Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.     MESA LABORATORIES, INC. (Registrant)     DATED: February 6, 2023 BY: /s/ Gary M. Owens . Gary M. Owens Chief Executive Officer             DATED: February 6, 2023 BY: /s/ John V. Sakys John V. Sakys Chief Financial Officer                         Page 25